Betamethasone Dipropionate Augmented Lotion

Treatment of Inflammatory and Pruritic Manifestations of Dermatoses: Such as eczema, psoriasis, and other corticosteroid-responsive dermatoses.

• Known hypersensitivity to betamethasone dipropionate or any other components of the formulation.
• Untreated bacterial, viral, or fungal skin infections, as corticosteroids can exacerbate these conditions.

• Apply the medication exactly as prescribed and avoid using it on the face, groin, or underarms unless directed by a healthcare provider.
• Avoid using the lotion for extended periods or on large areas of the body unless instructed by a healthcare provider, as prolonged use can lead to skin thinning and other side effects.
• Report any signs of skin irritation, such as redness, burning, or itching, to their healthcare provider.
• Use caution to avoid applying the lotion near the eyes or mouth, as this can cause irritation or other adverse effects.
• Store the lotion at room temperature and keep it out of reach of children.

• Skin irritation, redness, or burning at the application site
• Dryness or peeling of the skin
• Itching or stinging

• Skin Atrophy: Thinning of the skin, stretch marks, or easy bruising, especially with prolonged use.
• HPA Axis Suppression: Prolonged use of potent topical corticosteroids can lead to systemic absorption, potentially causing adrenal suppression.
• Allergic Reactions: Symptoms may include rash, itching, swelling, or difficulty breathing. If these occur, discontinue use and seek medical attention immediately.

• Systemic Absorption: Prolonged use of potent corticosteroids, especially on large body areas or under occlusion, can lead to systemic absorption, potentially resulting in adrenal suppression or Cushing's syndrome.
• Skin Thinning (Atrophy): Long-term use of topical corticosteroids can cause thinning of the skin, making it more susceptible to injury and infection.
• Use in Children: Children may be more susceptible to systemic toxicity due to their larger skin surface area relative to body weight. Use in pediatric patients should be limited to the least amount necessary for the shortest duration possible.

• Other Topical Corticosteroids: Concurrent use with other corticosteroids can increase the risk of side effects.
• Topical Retinoids or Acids: Using this lotion with other skin treatments that have a peeling effect may increase irritation.

Patients should inform their healthcare provider of all medications and skincare products they are using to avoid potential interactions.

• Other Topical Corticosteroids: Such as hydrocortisone for milder cases or clobetasol for more severe cases.
• Topical Calcineurin Inhibitors: Such as tacrolimus or pimecrolimus, which can be used as steroid-sparing agents.
• Moisturizers and Emollients: To help maintain skin hydration and barrier function, particularly in conditions like eczema.
• Phototherapy: For conditions like psoriasis, where light therapy can be effective.

The choice of treatment depends on the severity of the condition, the patient’s skin type, and their response to previous treatments.